Lv3
356 积分 2020-06-17 加入
[Consensus on the detection of microsatellite instability in colorectal cancer and other related solid tumors in China]
11小时前
待确认
Comment on “Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM Database”
8天前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
18天前
已完结
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
1个月前
已完结
Anticancer Effect of Active Component of Astragalus Membranaceus Combined with Olaparib on Ovarian Cancer Predicted by Network-Based Pharmacology
1个月前
已完结
PARP抑制剂不良反应管理的中国专家共识(2021年版)
1个月前
已完结
Targeting Protein Kinase, Membrane-Associated Tyrosine/Threonine 1 (PKMYT1) for Precision Cancer Therapy: From Discovery to Clinical Trial
2个月前
已完结
[Consensus on the molecular residual disease testing in solid tumor]
2个月前
已完结
PFKL promotes cell viability and glycolysis and inhibits cisplatin chemosensitivity of laryngeal squamous cell carcinoma
2个月前
已完结
结直肠癌KRAS基因突变检测专家共识
2个月前
已完结
皖公网安备34019202002308
